PMI reports full-year 2025 results with net revenues of $40.6 billion and smoke-free net revenues were about $16.9 billion

Feb.06

Philip Morris International (PMI) released its Q4 and full-year 2025 results on February 6, 2026. PMI reported full-year net revenues of $40,648 million ($40.6 billion), reported diluted EPS of $7.26 and adjusted diluted EPS of $7.54. PMI said smoke-free net revenues were $16.9 billion and represented 41.5% of total net revenues, with smoke-free products available in 106 markets and over 43 million estimated adult consumers.

Key Takeaways

Release date/coverage: February 6, 2026; Q4 2025 and full-year 2025 results
Full-year headline figures: net revenues $40,648 million; reported diluted EPS $7.26; adjusted diluted EPS $7.54
Smoke-free: shipment volumes +12.8% YoY; smoke-free net revenues $16.9 bn; 41.5% of total net revenues; available in 106 markets with over 43 million estimated adult consumers
Category updates: IQOS ~76% global category volume share; ZYN 196 million cans (Q4) and 794 million cans (FY); VEEV available in 47 markets with FY volumes “more than doubled”
Outlook/targets: 2026 adjusted diluted EPS $8.38–$8.53; 2026–2028 targets include organic net revenues CAGR 6%–8%, organic operating income CAGR 8%–10%, and adjusted diluted EPS excluding currency CAGR 9%–11%

2Firsts, February 6, 2026

According to Philip Morris International’s earnings release, PMI reported its fourth-quarter and full-year 2025 results and issued its 2026 outlook and 2026–2028 growth targets.

PMI reported full-year 2025 net revenues of $40,648 million (vs. $37,878 million in 2024) and disclosed reported diluted EPS of $7.26 and adjusted diluted EPS of $7.54 for 2025.

On smoke-free, PMI said full-year smoke-free shipment volumes increased 12.8%, with smoke-free net revenues of $16.9 billion and the smoke-free business accounting for 41.5% of total net revenues. PMI also said its smoke-free products are available in 106 markets with over 43 million estimated adult consumers.

On heat-not-burn, PMI said IQOS continued to drive the growth of the global category where PMI holds approximately 76% volume share, describing IQOS as the second largest nicotine “brand” in markets where present and holding the #1 volume share position in 13 markets.

On oral smoke-free, PMI said ZYN held around two-thirds value share in 2025 and reported ZYN shipments of 196 million cans in Q4 and 794 million cans for the full year.

On e-vapor, PMI said VEEV is available in 47 markets, with shipment volumes “more than doubled” on a full-year basis, and stated VEEV holds the #1 closed-pod volume share position in 8 markets.

For 2026, PMI forecast reported diluted EPS of $7.87–$8.02 and adjusted diluted EPS of $8.38–$8.53, and provided an adjusted diluted EPS excluding currency range of $8.11–$8.26.

PMI also provided 2026–2028 compound annual growth targets of 6%–8% for organic net revenues, 8%–10% for organic operating income, and 9%–11% for adjusted diluted EPS excluding currency, assuming current corporate income tax rates and no share repurchases.

Image source: PMI

2FIRSTS | 2Firsts Flash｜PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues

Philip Morris International reported full-year 2025 results on February 6, with smoke-free products accounting for 41.5% of adjusted net revenues, up from 38.7% a year earlier. Total net revenues rose 7.3% to $40.65 billion, while shipment volumes increased 1.4%, widening the gap between revenue and volume growth. Cigarette shipments declined as smoke-free volumes rose 12.8%, driven by heated tobacco, oral nicotine and e-vapor products. Results were released alongside a 9:00 a.m. EST webcast.

www.2firsts.com

References:

[1] Philip Morris International Reports 2025 Fourth-Quarter & Full-Year Results

Also Read:

[1] PMI Reports Strong Financial Performance for 2024 with a 7.3% Revenue Increase

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com